Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Christensen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Sports Physical Therapy|October 24, 2012
The acute effects of various types of stretching static, dynamic, ballistic, and no stretch of the iliopsoas on 40-yard sprint times in recreational runnersHarvey W Wallmann, Scott D Christensen, Craig Perry, et al.
The Breast Journal|January 12, 2008
Metastatic breast cancer mimicking benign fatty liver infiltrationSteve R Martinez, Rosalie J Hagge, Scott D Christensen, et al.
Journal of Oncology Practice|September 3, 2011
A model for rural oncologyLaurence J Heifetz, Scott D Christensen, Ralph W Devere-White, et al.
JAMA Surgery|April 5, 2013
Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremitiesNabil Wasif, Caitlin A Smith, Robert M Tamurian, et al.
Annals of Surgical Oncology|February 21, 2014
Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremityRobert J Canter, Dariusz Borys, Abimbola Olusanya, et al.
Investigational New Drugs|October 23, 2010
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trialTianhong Li, Scott D Christensen, Paul H Frankel, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2013
Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528Shirish M Gadgeel, Danika L Lew, Timothy W Synold, et al.
Journal of the American Water Resources Association|August 20, 2019
A High-Resolution National-Scale Hydrologic Forecast System from a Global Ensemble Land Surface ModelAlan D Snow, Scott D Christensen, Nathan R Swain, et al.
Journal of the American Academy of Dermatology|August 12, 2015
100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case seriesVivian Y Shi, Khiem Tran, Forum Patel, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Sports Physical Therapy|October 24, 2012
The acute effects of various types of stretching static, dynamic, ballistic, and no stretch of the iliopsoas on 40-yard sprint times in recreational runnersHarvey W Wallmann, Scott D Christensen, Craig Perry, et al.
The Breast Journal|January 12, 2008
Metastatic breast cancer mimicking benign fatty liver infiltrationSteve R Martinez, Rosalie J Hagge, Scott D Christensen, et al.
Journal of Oncology Practice|September 3, 2011
A model for rural oncologyLaurence J Heifetz, Scott D Christensen, Ralph W Devere-White, et al.
JAMA Surgery|April 5, 2013
Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremitiesNabil Wasif, Caitlin A Smith, Robert M Tamurian, et al.
Annals of Surgical Oncology|February 21, 2014
Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremityRobert J Canter, Dariusz Borys, Abimbola Olusanya, et al.
Investigational New Drugs|October 23, 2010
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trialTianhong Li, Scott D Christensen, Paul H Frankel, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2013
Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528Shirish M Gadgeel, Danika L Lew, Timothy W Synold, et al.
Journal of the American Water Resources Association|August 20, 2019
A High-Resolution National-Scale Hydrologic Forecast System from a Global Ensemble Land Surface ModelAlan D Snow, Scott D Christensen, Nathan R Swain, et al.
Journal of the American Academy of Dermatology|August 12, 2015
100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case seriesVivian Y Shi, Khiem Tran, Forum Patel, et al.
Pageof 1